BioDuro

BioDuro, established in 1996, is a global contract research, development, and manufacturing organization (CRDMO) operating within the Pharmaceuticals and Healthcare sectors. Headquartered in Irvine, California, the company focuses on providing comprehensive, end-to-end services to biotech and pharmaceutical partners. BioDuro supports the entire drug development lifecycle, from initial target identification through to commercial drug product manufacturing, leveraging its expertise to accelerate client innovation and market entry. The organization's core capabilities span discovery chemistry, medicinal chemistry, computational chemistry, discovery biology, and DMPK, alongside oncology pharmacology. BioDuro also excels in drug substance manufacturing and drug product development, featuring specialized technology platforms such as hot melt extrusion, spray dried dispersion, and bioavailability enhancement for oral solid dosage forms. With an employee range of 1,000-5,000 individuals, BioDuro is equipped to handle complex projects and offers insights into their operational structure through Meet BioDuro's team. BioDuro provides critical support for IND-enabling studies, clinical trial material manufacturing, and GMP-compliant commercial production. The company serves clients across the pharmaceutical and biotechnology industries with adaptable service models, including integrated programs, FTE, and fee-for-service arrangements. Operating across seven sites in the United States and China, BioDuro generated $675.1M in revenue, demonstrating significant market presence and capacity to deliver integrated solutions for drug development and manufacturing.